| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_dea3b49d486c3d5d29c48d8e2d53b52e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_984d288223c214a8d0117f8bf727df14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_969398f2c82d15aa736111d048487bb8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_04f0ac55007351b20232adea428f3db6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4a4a38caa6f1c63f6e5ab0f03f86269a |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-405
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-19
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-185
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-198
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-401
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-385 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-198
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-401
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-405 |
| filingDate |
2006-11-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9e38a18fdca96cc202d9094d2149ba87
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_91eaf7a4f21600fd87e8c23795dc5427
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_166daf916746dc5821c2f12fe17e8017
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_eaf4e3fdc41896d5fb7cb1852ae258ae |
| publicationDate |
2007-05-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2007053943-A1 |
| titleOfInvention |
The use of compositions comprising ketoacids and amino acids for increasing muscle mass and muscle performance |
| abstract |
Compositions and methods relating to the use of cationic and monobasic amino acids combined with ketoacids for the purposes of regulating molecular signals to control anabolic and anti-catabolic activity in skeletal muscular development are disclosed. The present invention is designed to influence the genetic control system for muscle protein synthesis to stimulate muscle growth, increase muscle mass, decrease muscle catabolism, decrease recovery time and to treat muscle wasting and/or degeneration. Said compositions are to be administered to a subject one to four times daily. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2009094750-A1 |
| priorityDate |
2005-11-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |